Home › Prostate Cancer › Minnesota › Rochester
Prostate Cancer clinical trials in Rochester, MN
20 studies for Prostate Cancer are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recruiting
- Mayo Clinic, Rochester
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecruitingPhase 3
- Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecruitingPhase 1
- Mayo Clinic, Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RecruitingPhase 1
- Mayo Clinic, Rochester
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- Research Site, Rochester
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
RecruitingPhase 3
- Research Site, Rochester
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Recruiting
- Mayo Clinic in Rochester, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Mayo Clinic, Rochester
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
RecruitingPhase 1/2
- GSK Investigational Site, Rochester
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RecruitingPhase 3
- Mayo Clinic- Rochester, Rochester
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Recruiting
- Mayo Clinic in Rochester, Rochester
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
RecruitingHealthy volunteers welcome
- Mayo Clinic in Rochester, Rochester
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RecruitingPhase 4
- Mayo Clinic Rochester, Rochester
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
RecruitingObservational studyHealthy volunteers welcome
- Mayo Clinic in Rochester, Rochester
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecruitingPhase 1/2
- Mayo Clinic, Rochester
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
RecruitingObservational studyHealthy volunteers welcome
- Mayo Clinic in Rochester, Rochester
Understanding of Genetics by Men at Risk for Prostate Cancer
RecruitingHealthy volunteers welcome
- Mayo Clinic, Rochester
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Rochester
- Breast Cancer39 studies
- Non-Small Cell Lung Cancer38 studies
- Cancer (all types)31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer27 studies
- Colorectal Cancer27 studies
- Multiple Myeloma25 studies
- Heart Failure21 studies
- Lung Cancer21 studies
- Pancreatic Cancer20 studies
- Chronic Lymphocytic Leukemia20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.